NRX Pharmaceuticals (NRXP) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
NRXP is expected to report earnings to fall 90.00% to -5 cents per share on May 14
Q1'24
Est.
$-0.05
Q4'23
Missed
by $0.43
Q3'23
Beat
by $0.04
Q2'23
Beat
by $0.01
Q1'23
Missed
by $0.02
The last earnings report on March 28 showed earnings per share of -50 cents, missing the estimate of -7 cents. With 856.51K shares outstanding, the current market capitalization sits at 19.83M.